FTDI
VRTX icon

First Trust Direct Indexing’s Vertex Pharmaceuticals VRTX Stock Holding History

First Trust Direct Indexing’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,868
Closed -$2.73M – 906
2024
Q3 		$2.73M Buy
5,868
+335
+6% +$161K 0.15% 132
2024
Q2 		$2.59M Buy
5,533
+1,415
+34% +$614K 0.16% 115
2024
Q1 		$1.72M Buy
4,118
+666
+19% +$282K 0.13% 166
2023
Q4 		$1.4M Buy
3,452
+1,186
+52% +$438K 0.13% 182
2023
Q3 		$788K Buy
2,266
+216
+11% +$75.5K 0.09% 271
2023
Q2 		$721K Buy
2,050
+263
+15% +$88.6K 0.08% 300
2023
Q1 		$563K Buy
1,787
+91
+5% +$27.3K 0.07% 366
2022
Q4 		$490K Buy
1,696
+1
+0.1% +$305 0.07% 387
2022
Q3 		$491K Buy
1,695
+167
+11% +$48K 0.07% 344
2022
Q2 		$431K Buy
1,528
+106
+7% +$28.4K 0.06% 380
2022
Q1 		$371K Buy
1,422
+145
+11% +$34.4K 0.05% 443
2021
Q4 		$280K Buy
1,277
+44
+4% +$8.56K 0.04% 507
2021
Q3 		$224K Sell
1,233
-312
-20% -$60.9K 0.03% 560
2021
Q2 		$312K Sell
1,545
-942
-38% -$197K 0.05% 453
2021
Q1 		$534K Sell
2,487
-1,443
-37% -$317K 0.14% 196
2020
Q4 		$929K Buy
+3,930
New +$902K 0.25% 90

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

First Trust Direct Indexing's VRTX Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Vertex Pharmaceuticals (VRTX) in Q4 2024, closing a stake of 5,868 shares — an estimated $2.73M sold.

First Trust Direct Indexing first reported a position in VRTX in Q4 2020 and held it in 16 quarters. The position peaked at $2.73M in Q3 2024. 1,557 funds tracked by Wall St. Rank hold VRTX as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Vertex Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 5,868 Vertex Pharmaceuticals shares in Q4 2024, an estimated $2.73M.
  • First Trust Direct Indexing first reported a position in Vertex Pharmaceuticals in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Vertex Pharmaceuticals position peaked at $2.73M in Q3 2024.
  • 1,557 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.